Search research articles
Contact Us
Filters
Showing results (671-680 of 711) with videos related to
Page
of 72
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 15, 2003
Cantuzumab mertansine, a maytansinoid immunoconjugate directed to the CanAg antigen: a phase I, pharmacokinetic, and biologic correlative study
Anthony W Tolcher, Leonel Ochoa, Lisa A Hammond, et al.
Nature Human Behaviour
|
June 29, 2021
A review and agenda for integrated disease models including social and behavioural factors
Jamie Bedson, Laura A Skrip, Danielle Pedi, et al.
American Journal of Pharmaceutical Education
|
July 20, 2017
Perceived Motivating Factors and Barriers for the Completion of Postgraduate Training Among American Pharmacy Students Prior to Beginning Advanced Pharmacy Practice Experiences
Drayton A Hammond, Douglas R Oyler, John W Devlin, et al.
The Journal of Experimental Medicine
|
April 26, 2022
In vivo labeling reveals continuous trafficking of TCF-1+ T cells between tumor and lymphoid tissue
Zhi Li, Zewen K Tuong, Isaac Dean, et al.
Cancer Immunology Research
|
June 16, 2025
In Vivo Labeling Resolves Distinct Temporal, Spatial, and Functional Properties of Tumor Macrophages and Identifies Subset-Specific Effects of PD-L1 Blockade
Colin Y C Lee, Isaac Dean, Nathan Richoz, et al.
Circulation. Heart Failure
|
March 11, 2018
Long-Term Cognitive Decline After Newly Diagnosed Heart Failure: Longitudinal Analysis in the CHS (Cardiovascular Health Study)
Christa A Hammond, Natalie J Blades, Sarwat I Chaudhry, et al.
Mabs
|
January 5, 2021
Activity of murine surrogate antibodies for durvalumab and tremelimumab lacking effector function and the ability to deplete regulatory T cells in mouse models of cancer
Darren J Schofield, Jennifer Percival-Alwyn, Mateusz Rytelewski, et al.
Blood Advances
|
November 8, 2019
Replication timing alterations in leukemia affect clinically relevant chromosome domains
Juan Carlos Rivera-Mulia, Takayo Sasaki, Claudia Trevilla-Garcia, et al.
Cancer Biology & Therapy
|
January 11, 2024
Efficacy and pharmacodynamic effect of anti-CD73 and anti-PD-L1 monoclonal antibodies in combination with cytotoxic therapy: observations from mouse tumor models
Brajesh P Kaistha, Gozde Kar, Andreas Dannhorn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 19, 2000
Phase I and pharmacokinetic study of irofulven, a novel mushroom-derived cytotoxin, administered for five consecutive days every four weeks in patients with advanced solid malignancies
S G Eckhardt, S D Baker, C D Britten, et al.
Page
of 72
Search research articles
Search
Showing results (671-680 of 711) with videos related to
Sort By:
Page
of 72
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 15, 2003
Cantuzumab mertansine, a maytansinoid immunoconjugate directed to the CanAg antigen: a phase I, pharmacokinetic, and biologic correlative study
Anthony W Tolcher, Leonel Ochoa, Lisa A Hammond, et al.
Nature Human Behaviour
|
June 29, 2021
A review and agenda for integrated disease models including social and behavioural factors
Jamie Bedson, Laura A Skrip, Danielle Pedi, et al.
American Journal of Pharmaceutical Education
|
July 20, 2017
Perceived Motivating Factors and Barriers for the Completion of Postgraduate Training Among American Pharmacy Students Prior to Beginning Advanced Pharmacy Practice Experiences
Drayton A Hammond, Douglas R Oyler, John W Devlin, et al.
The Journal of Experimental Medicine
|
April 26, 2022
In vivo labeling reveals continuous trafficking of TCF-1+ T cells between tumor and lymphoid tissue
Zhi Li, Zewen K Tuong, Isaac Dean, et al.
Cancer Immunology Research
|
June 16, 2025
In Vivo Labeling Resolves Distinct Temporal, Spatial, and Functional Properties of Tumor Macrophages and Identifies Subset-Specific Effects of PD-L1 Blockade
Colin Y C Lee, Isaac Dean, Nathan Richoz, et al.
Circulation. Heart Failure
|
March 11, 2018
Long-Term Cognitive Decline After Newly Diagnosed Heart Failure: Longitudinal Analysis in the CHS (Cardiovascular Health Study)
Christa A Hammond, Natalie J Blades, Sarwat I Chaudhry, et al.
Mabs
|
January 5, 2021
Activity of murine surrogate antibodies for durvalumab and tremelimumab lacking effector function and the ability to deplete regulatory T cells in mouse models of cancer
Darren J Schofield, Jennifer Percival-Alwyn, Mateusz Rytelewski, et al.
Blood Advances
|
November 8, 2019
Replication timing alterations in leukemia affect clinically relevant chromosome domains
Juan Carlos Rivera-Mulia, Takayo Sasaki, Claudia Trevilla-Garcia, et al.
Cancer Biology & Therapy
|
January 11, 2024
Efficacy and pharmacodynamic effect of anti-CD73 and anti-PD-L1 monoclonal antibodies in combination with cytotoxic therapy: observations from mouse tumor models
Brajesh P Kaistha, Gozde Kar, Andreas Dannhorn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 19, 2000
Phase I and pharmacokinetic study of irofulven, a novel mushroom-derived cytotoxin, administered for five consecutive days every four weeks in patients with advanced solid malignancies
S G Eckhardt, S D Baker, C D Britten, et al.
Page
of 72